Download PDF
Semin intervent Radiol 2023; 40(01): 027-032
DOI: 10.1055/s-0043-1764286
Review Article

Transjugular Intrahepatic Portosystemic Shunt Reduction Techniques

Mason A. Brown
1   Department of Vascular and Interventional Radiology, Aurora St. Luke's Medical Center, Milwaukee, Wisconsin
,
Sebouh Gueyikian
2   Department of Vascular and Interventional Radiology, NorthShore University HealthSystem, Evanston, Illinois
,
Steven Huffman
1   Department of Vascular and Interventional Radiology, Aurora St. Luke's Medical Center, Milwaukee, Wisconsin
,
Laurence Donahue
1   Department of Vascular and Interventional Radiology, Aurora St. Luke's Medical Center, Milwaukee, Wisconsin
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) creation treats complications of portal hypertension in appropriately selected patients by lowering the portal venous pressure. While this can be a lifesaving intervention, portal venous flow diversion is not without potential consequences. Overshunting can lead to hepatic decompensation and encephalopathy. TIPS reduction and TIPS occlusion are therapeutic options used to mitigate overshunting, with reduction being the initial alternative due to retained shunt patency and lower potential for venous thrombosis. Patient selection, techniques for TIPS reduction, and patient outcomes are reviewed in this article.

Keywords

occlusion - overt hepatic encephalopathy - portal hypertension - TIPS reduction - varices - interventional radiology


Publication History

Article published online:
04 May 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol 2014; 31 (03) 235-242
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Suhocki PV, Lungren MP, Kapoor B, Kim CY. Transjugular intrahepatic portosystemic shunt complications: prevention and management. Semin Intervent Radiol 2015; 32 (02) 123-132
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Van der Linden P, Le Moine O, Ghysels M, Ortinez M, Devière J. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology 1996; 23 (05) 982-987
    CrossrefPubMedGoogle Scholar
  • 4 Schindler P, Heinzow H, Trebicka J, Wildgruber M. Shunt-induced hepatic encephalopathy in TIPS: current approaches and clinical challenges. J Clin Med 2020; 9 (11) 3784
    CrossrefPubMedGoogle Scholar
  • 5 Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 1978; 23 (05) 398-406
    CrossrefPubMedGoogle Scholar
  • 6 Joseph AS, Sandhu B, Khalil A, Lopera J. Transjugular portosystemic shunt reductions: a retrospective single-center experience. J Vasc Interv Radiol 2019; 30 (06) 876-884
    CrossrefPubMedGoogle Scholar
  • 7 Wijdicks EF. Hepatic encephalopathy. N Engl J Med 2016; 375 (17) 1660-1670
    CrossrefPubMedGoogle Scholar
  • 8 de Wit K, Schaapman JJ, Nevens F. et al. Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial). BMJ Open Gastroenterol 2020; 7 (01) e000531
    CrossrefPubMedGoogle Scholar
  • 9 Taylor AG, Kolli KP, Kerlan Jr RK. Techniques for transjugular intrahepatic portosystemic shunt reduction and occlusion. Tech Vasc Interv Radiol 2016; 19 (01) 74-81
    CrossrefPubMedGoogle Scholar
  • 10 Kochar N, Tripathi D, Ireland H, Redhead DN, Hayes PC. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut 2006; 55 (11) 1617-1623
    CrossrefPubMedGoogle Scholar
  • 11 Bilbao JI, Quiroga J, Herrero JI, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities. Cardiovasc Intervent Radiol 2002; 25 (04) 251-269
    CrossrefPubMedGoogle Scholar
  • 12 Casadaban LC, Parvinian A, Minocha J. et al. Clearing the confusion over hepatic encephalopathy after TIPS creation: incidence, prognostic factors, and clinical outcomes. Dig Dis Sci 2015; 60 (04) 1059-1066
    CrossrefPubMedGoogle Scholar
  • 13 Riggio O, Merlli M, Pedretti G. et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci 1996; 41 (03) 578-584
    CrossrefPubMedGoogle Scholar
  • 14 Gaba RC, Lakhoo J. What constitutes liver failure after transjugular intrahepatic portosystemic shunt creation? A proposed definition and grading system. Ann Hepatol 2016; 15 (02) 230-235
    PubMedGoogle Scholar
  • 15 Paz-Fumagalli R, Crain MR, Mewissen MW, Varma RR. Fatal hemodynamic consequences of therapeutic closure of a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 1994; 5 (06) 831-834
    CrossrefPubMedGoogle Scholar
  • 16 Rose SE, Katz MD. Intentional occlusion of a transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol 1995; 18 (02) 109-111
    CrossrefPubMedGoogle Scholar
  • 17 Haskal ZJ, Cope C, Soulen MC, Shlansky-Goldberg RD, Baum RA, Redd DC. Intentional reversible thrombosis of transjugular intrahepatic portosystemic shunts. Radiology 1995; 195 (02) 485-488
    CrossrefPubMedGoogle Scholar
  • 18 Kerlan Jr RK, LaBerge JM, Baker EL. et al. Successful reversal of hepatic encephalopathy with intentional occlusion of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1995; 6 (06) 917-921
    CrossrefPubMedGoogle Scholar
  • 19 Freedman AM, Sanyal AJ, Tisnado J. et al. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review. Radiographics 1993; 13 (06) 1185-1210
    CrossrefPubMedGoogle Scholar
  • 20 Jalan R, Hayes PC. Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. Radiology 1995; 197 (03) 587
    CrossrefPubMedGoogle Scholar
  • 21 Gerbes AL, Waggershauser T, Holl J, Gülberg V, Fischer G, Reiser M. Experiences with novel techniques for reduction of stent flow in transjugular intrahepatic portosystemic shunts. Z Gastroenterol 1998; 36 (05) 373-377
    PubMedGoogle Scholar
  • 22 Haskal ZJ, Middlebrook MR. Creation of a stenotic stent to reduce flow through a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 1994; 5 (06) 827-829 , discussion 829–830
    CrossrefPubMedGoogle Scholar
  • 23 Patel RK, Chandel K, Tripathy TP, Mukund A. Complications of transjugular intrahepatic portosystemic shunt (TIPS) in the era of the stent graft - What the interventionists need to know?. Eur J Radiol 2021; 144: 109986
    CrossrefPubMedGoogle Scholar
  • 24 Blue RC, Lo GC, Kim E. et al. Transjugular intrahepatic portosystemic shunt flow reduction with adjustable polytetrafluoroethylene-covered balloon-expandable stents using the “sheath control” technique. Cardiovasc Intervent Radiol 2016; 39 (06) 935-939
    CrossrefPubMedGoogle Scholar
  • 25 Sarwar A, Esparaz AM, Chakrala N. et al. Efficacy of TIPS reduction for refractory hepatic encephalopathy, right heart failure, and liver dysfunction. AJR Am J Roentgenol 2021; 216 (05) 1267-1272
    CrossrefPubMedGoogle Scholar
  • 26 Fanelli F, Salvatori FM, Rabuffi P. et al. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft. AJR Am J Roentgenol 2009; 193 (06) 1696-1702
    CrossrefPubMedGoogle Scholar